Replies to post #8623 on ProtoKinetix Inc (PKTX)

[scoobey-do]

Great quote, in fact this part is even worth repeating:

"At the 6-month time point, the AAGP®-treated cells acquired the ability to express retinal and synaptic proteins, confirming that AAGP® has no adverse effect on precursor cells’ maturation."

PKTX's time will be coming soon.